These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Accession to the PIC/S and pharmaceutical quality system in Japan]. Katori N Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):22-35. PubMed ID: 25707200 [TBL] [Abstract][Full Text] [Related]
4. Ingredients in pharmaceutical preparations: a problem not value. Lubner GC Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372 [No Abstract] [Full Text] [Related]
5. PDA comments: PIC draft recommendations on the inspection of isolator technology. Parenteral Drug Association. PDA J Pharm Sci Technol; 1999; 53(3):141-7. PubMed ID: 10754704 [No Abstract] [Full Text] [Related]
6. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organization World Health Organ Tech Rep Ser; 2012; (970):1-235, back cover. PubMed ID: 22894011 [TBL] [Abstract][Full Text] [Related]
8. PDA comments on draft guidance for industry on changes to an approved NDA or ANDA. Parenteral Drug Association. PDA J Pharm Sci Technol; 1999; 53(5):264-72. PubMed ID: 10754723 [No Abstract] [Full Text] [Related]
9. PDA comments: ICH Q6A; draft guidance on specifications. Parenteral Drug Association. PDA J Pharm Sci Technol; 1998; 52(5):232-3. PubMed ID: 9846071 [No Abstract] [Full Text] [Related]
10. WHO Expert Committee on specifications for pharmaceutical preparations. World Health Organization Expert Committee World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300 [TBL] [Abstract][Full Text] [Related]
11. Drug recalls as viewed by the manufacturer. Mitchell CM J Am Pharm Assoc; 1967 Nov; 7(11):575-7. PubMed ID: 6063674 [No Abstract] [Full Text] [Related]
12. Quality assurance during the production process. Tucker JD Med Serv J Can; 1967 Mar; 23(3):262-9. PubMed ID: 6056371 [No Abstract] [Full Text] [Related]
13. [Official inspections of a pharmaceutical plant during the registration of new products]. De Martiis F; Fontani F; Zanotti-Gerosa A Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440 [No Abstract] [Full Text] [Related]
15. [Quality control in the pharmaceutical industry]. Bretscher E Pharm Acta Helv; 1972; 47(11):664-75. PubMed ID: 4657535 [No Abstract] [Full Text] [Related]
16. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
17. [Various aspects of the significance of government control in drug supply]. Teijgeler CA; Samsom RJ Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999 [No Abstract] [Full Text] [Related]
18. Pharmaceutical drugs-the good and the not so good: together, we can make it better. Campbell AW Altern Ther Health Med; 2014; 20(1):9-11. PubMed ID: 24445351 [No Abstract] [Full Text] [Related]